市场调查报告书
商品编码
1547785
全球医疗外骨骼市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势和预测Global Medical Exoskeleton Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032 |
全球医疗外骨骼市场需求预计将从 2023 年的 3,724.2 亿美元达到近 9,9522.4 亿美元的市场规模,2024-2032 年研究期间复合年增长率为 44.06%。
医用外骨骼是可穿戴机器人设备,旨在帮助行动障碍或残疾的个人,使他们能够站立、行走或进行其他日常生活活动。这些设备为使用者的肌肉骨骼系统提供外部支持和帮助,增强他们的力量和活动能力。它通常由佩戴在使用者四肢或躯干上的轻型可调框架以及检测和响应用户运动的马达、感测器和控制系统组成。它们用于復健环境,透过提供有针对性的物理治疗和步态训练,帮助个人从损伤或神经系统疾病(如脊髓损伤、中风或多发性硬化症)中恢復。
由于神经系统疾病和脊髓损伤的日益流行,医疗外骨骼行业正在经历显着增长,这需要先进的復健解决方案。这些设备为患有这些疾病的人提供了增强的移动性和独立性,显着提高了他们的生活品质。机器人和穿戴式装置的技术进步促进了更高效、更轻量和用户友好的外骨骼的开发,使它们更容易为更广泛的患者群体所使用。此外,随着老年人寻求行动和日常活动的帮助,全球人口老化也增加了对这些设备的需求。医疗保健专业人员和患者的认识和接受度不断提高,也推动了该行业的发展。
此外,研发方面的大量投资正在推动创新,从而产生更有效、更实惠的解决方案。医疗机构越来越多地将外骨骼纳入其復健计划,以改善患者的治疗效果并缩短復原时间。监管部门的批准和积极的临床试验结果进一步验证了这些设备的功效和安全性,从而促进了它们的采用。支持先进医疗设备开发和部署的政府倡议和资金也在该行业的成长中发挥着至关重要的作用。随着技术的不断发展和其优势得到更广泛的认可,该行业已做好持续扩张的准备,为行动障碍提供变革性的解决方案。然而,高昂的成本和有限的可近性可能会阻碍未来几年医疗外骨骼市场的成长。
研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外,这些工具也对全球医疗外骨骼市场的各个细分市场进行了包容性评估。医疗外骨骼产业的成长和趋势为本研究提供了整体方法。
医疗外骨骼市场报告的这一部分提供了国家和地区层面细分市场的详细资料,从而帮助策略师确定相应产品或服务的目标人群以及即将到来的机会。
本节涵盖区域前景,重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲医疗外骨骼市场当前和未来的需求。此外,该报告重点关注所有主要地区各个应用领域的需求、估计和预测。
该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。医疗外骨骼市场的主要参与者包括Ekso Bionics(美国)、ReWalk(以色列)、Parker Hannifin(美国)、Cyberdyne(日本)和Bionik(加拿大)、Rex Bionics(英国)、B-TEMIA Inc. (加拿大) 、Bioventus(北卡罗来纳州)、Hocoma AG(DIH Technologies 子公司)(瑞士)、Wearable Robotics SRL(义大利)、Gogoa Mobility Robots SL(西班牙)、ExoAtlet(卢森堡)、Meditouch(以色列)、Suit X (美国) 、P&S Mechanics(韩国)、Marsi Bionics(西班牙)、Rehab Robotics(香港)、Myomo(美国)。本节包含竞争格局的整体视图,包括各种策略发展,例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。
如果您有任何客製化要求,请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。
The global demand for Medical Exoskeleton Market is presumed to reach the market size of nearly USD 9952.24 Billion by 2032 from USD 372.42 Billion in 2023 with a CAGR of 44.06% under the study period 2024-2032.
Medical exoskeletons are wearable robotic devices designed to assist individuals with mobility impairments or disabilities, enabling them to stand, walk, or perform other activities of daily living. These devices provide external support and assistance to the user's musculoskeletal system, augmenting their strength and mobility. It typically consist of lightweight, adjustable frames worn over the user's limbs or torso, along with motors, sensors, and control systems that detect and respond to the user's movements. They are used in rehabilitation settings to help individuals recover from injuries or neurological conditions, such as spinal cord injury, stroke, or multiple sclerosis, by providing targeted physical therapy and gait training.
The medical exoskeleton industry is witnessing significant growth driven by the increasing prevalence of neurological disorders and spinal cord injuries, which necessitate advanced rehabilitation solutions. These devices offer enhanced mobility and independence to individuals with these conditions, significantly improving their quality of life. Technological advancements in robotics and wearable devices have led to the development of more efficient, lightweight, and user-friendly exoskeletons, making them more accessible to a broader patient base. Additionally, the aging global population is contributing to the demand for these devices as elderly individuals seek assistance with mobility and daily activities. The growing awareness and acceptance among healthcare professionals and patients alike are also propelling the industry forward.
Furthermore, substantial investments in research and development are driving innovation, resulting in more effective and affordable solutions. Healthcare facilities are increasingly incorporating exoskeletons into their rehabilitation programs to enhance patient outcomes and reduce recovery times. Regulatory approvals and positive clinical trial results are further validating the efficacy and safety of these devices, boosting their adoption. Government initiatives and funding to support the development and deployment of advanced medical devices are also playing a crucial role in the industry's growth. As the technology continues to evolve and the benefits become more widely recognized, the industry is poised for sustained expansion, offering transformative solutions for mobility impairments. However, high costs and limited accessibility may hinder the medical exoskeleton market growth in the next few years.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain Analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Medical Exoskeleton. The growth and trends of Medical Exoskeleton industry provide a holistic approach to this study.
This section of the Medical Exoskeleton market report provides detailed data on the segments at the country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the Medical Exoskeleton market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Medical Exoskeleton market include Ekso Bionics (US), ReWalk (Israel), Parker Hannifin (US), Cyberdyne (Japan) And Bionik (Canada), Rex Bionics (UK), B-TEMIA Inc. (Canada), Bioventus (North Carolina), Hocoma AG (A Subsidiary Of DIH Technologies) (Switzerland), Wearable Robotics SRL (Italy), Gogoa Mobility Robots SL (Spain), ExoAtlet (Luxembourg), Meditouch (Israel), Suit X (US), P&S Mechanics (South Korea), Marsi Bionics (Spain), Rehab Robotics (Hong Kong), Myomo (US). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.